and this is reflected in the breadth of topics being investigated by the small animal soft tissue surgery team. Current areas of investigation include: Investigation into pathogenicity factors in ...

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Soft Tissue Sarcoma.